(Q37708187)

22 August 2017

1 reference

title

Interactions between the immune system and cancer: a brief review of non-spatial mathematical models (English)

1 reference

22 August 2017

1 reference

Jonathan L Bramson

2

0 references

David J D Earn

series ordinal

3

object named as

David J D Earn

1 reference

22 August 2017

Raluca Eftimie

1

1 reference

22 August 2017

publication date

12 March 2010

1 reference

Bulletin of Mathematical Biology

22 August 2017

number of pages

31

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

22 August 2017

volume

73

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

2-32

1 reference

maintained by WikiProject

22 August 2017

WikiProject Mathematics

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s11538-010-9526-3

0 references

cites work

A history of the study of solid tumour growth: the contribution of mathematical modelling.

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Delay-induced model for tumor-immune interaction and control of malignant tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

IFN-gamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Human tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Mathematical model of BCG immunotherapy in superficial bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Cancer; a biological approach. I. The processes of control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Immunological aspects of malignant disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Modelling aspects of cancer dynamics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Cancer immunotherapy, mathematical modeling and optimal control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Gompertzian growth pattern correlated with phenotypic organization of colon carcinoma, malignant glioma and non-small cell lung carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Time accelerated Monte Carlo simulations of biological networks using the binomial tau-leap method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Estimating the growth kinetics of experimental tumors from as few as two determinations of tumor size: implications for clinical oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Dynamic response of cancer under the influence of immunological activity and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Role of IL-21 in immune-regulation and tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Cytokines in cancer pathogenesis and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

A survey of some formal models in tumor immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Evolution of cell motility in an individual-based model of tumour growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

A general method for numerically simulating the stochastic time evolution of coupled chemical reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Mathematical and computational models of immune-receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

On the Nature of the Function Expressive of the Law of Human Mortality, and on a New Mode of Determining the Value of Life Contingencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

The growth law of primary breast cancer as inferred from mammography screening trials data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Immunotherapy: target the stroma to hit the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Modeling immunotherapy of the tumor-immune interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Mutation and cancer: statistical study of retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

21 January 2018

DYNAMICS OF TUMOR GROWTH

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Cytokinetic analysis of tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Tumor-associated macrophages in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

A cellular automata model of tumor-immune system interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

The impact of "search precision" in an agent-based tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Evolutionary game theory in an agent-based brain tumor model: exploring the 'Genotype-Phenotype' link.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Growth factors and growth control of heterogeneous cell populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Tumor micro-ecology and competitive interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

The ecology and evolutionary biology of cancer: a review of mathematical models of necrosis and tumor cell diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

A mathematical model of cancer treatment by immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

The role of chromosomal instability in tumor initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Role of nitric oxide in IL-2 therapy-induced capillary leak syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Mathematical models of cancer dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

A mathematical model of drug resistance: heterogeneous tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Cancer immunotherapy: the past, the present and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Cytokines in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

CD4 cells can be more efficient at tumor rejection than CD8 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Dormant tumor cells as a therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Cancer self remission and tumor stability-- a stochastic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

A fresh look at tumor immunosurveillance and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Rates of growth of human neoplasms: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

A mathematical analysis of the interactions between immunogenic tumor cells and cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Immune-mediated dormancy: an equilibrium with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Combining experiments with multi-cell agent-based modeling to study biological tissue patterning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

A delay differential equation model for tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1alpha /beta released from neutrophils recruited by mast cell-derived TNFalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

NK cells and cancer immunosurveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

A mathematical model quantifies proliferation and motility effects of TGF-β on cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Macrophage-based anti-cancer therapy: modelling different modes of tumour targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

Breast cancer tumor growth estimated through mammography screening data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

CD4+ T-cell-mediated anti-tumor immunity can be uncoupled from autoimmunity via the STAT4/STAT6 signaling axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-010-9526-3

10.1007/S11538-010-9526-3

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference